PI3K inhibitors in haematological malignancies

Lancet Oncol. 2022 Aug;23(8):e365. doi: 10.1016/S1470-2045(22)00332-1.

¹ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: [email protected].
² Clinical Statistics, Bayer AG, Berlin, Germany.
³ Clinical Development, Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA.
⁴ IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seragnoli," Bologna, Italy; Dipartimento di Medicina Specialistica, Diagnostica e Sperintale, Universita di Bologna, Bologna, Italy.

No abstract available

Publication types